Evaluation of efficacy and safety of pegfilgrastim when given less than two weeks from dose-dense chemotherapy regimens.
J Oncol Pharm Pract. 2021 Jul;27(5):1119-1124. doi: 10.1177/1078155220948937. Epub 2020 Aug 12.
J Oncol Pharm Pract. 2021.
PMID: 32787561